The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision
- PMID: 32113887
- DOI: 10.1016/j.ejso.2020.02.034
The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision
Abstract
Aim: To investigate the impact of circumferential tumour location on neoadjuvant chemoradiotherapy (CRT) response and its prognostic value for locally advanced rectal cancer (LARC) patients after CRT and surgery.
Methods: A retrospective study was performed on 486 patients with LARC who received neoadjuvant CRT and surgical treatment. The rate of pathological complete response (pCR) and survival among patients with anteriorly, laterally, and posteriorly located tumours were compared. Logistic regression was performed to identify pCR predictors.
Results: The anterior tumours exhibited the highest pCR rate of 26.7%, which was slightly higher than the 20.0% and 12.3% for lateral and posterior tumours, respectively (P = 0.006). The 5-year Overall survival (OS) rates after CRT were similar among the anterior, lateral, and posterior groups (anterior vs lateral vs posterior: 81.1% vs 89.9% vs 84.1%, P = 0.6368). Multivariate analysis revealed that the circumferential tumour location, post-CRT serum CEA and post-CRT tumour thickness measured by MRI were independently correlated with achieving pCR.
Conclusion: This study is the first, to the best of our knowledge, to show that anterior LARC exhibited the highest pCR rate after neoadjuvant CRT. Patients with anterior rectal cancers do not have different prognoses from those with non-anterior cancers if they undergo neoadjuvant CRT.
Keywords: Circumferential tumour location; Locally advanced rectal cancer; Pathological complete response.
Copyright © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have no conflicts of interest to declare.
Comment in
-
Reply to: The impact of circumferential tumor location on the clinical outcomes of rectal cancers receiving neoadjuvant chemoradiation and surgery-does is really matter?Eur J Surg Oncol. 2020 Dec;46(12):2341-2342. doi: 10.1016/j.ejso.2020.07.024. Epub 2020 Jul 29. Eur J Surg Oncol. 2020. PMID: 32771249 No abstract available.
-
The impact of circumferential tumor location on the clinical outcomes of rectal cancers receiving neoadjuvant chemoradiation and surgery-does it really matter?Eur J Surg Oncol. 2020 Dec;46(12):2339-2340. doi: 10.1016/j.ejso.2020.07.023. Epub 2020 Jul 28. Eur J Surg Oncol. 2020. PMID: 32771250 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
